EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Frank Tacke, Dror Dicker, Paul Horn et al.|Journal of Hepatology|2024Cited by 1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentTae-Won Kang, Lars Zender, Anna Potapova et al.|Nature|2011Cited by 1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancerJakob Nikolas Kather, Tom Luedde, Alexander T. Pearson et al.|Nature Medicine|2019Cited by 1.4k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisChristoph Roderburg, Tom Luedde, Gerd-Willem Urban et al.|Hepatology|2010Cited by 786
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisScott L. Friedman, Éric Lefebvre, Vlad Ratziu et al.|Hepatology|2017Cited by 657